STENTiT Raises €1.8M in Seed Funding
- STENTiT, an Eindhoven, The Netherlands-based MedTech company, raised €1.8m in seed funding
- The round was made by NextGen Ventures, Brabant Development Agency (BOM) and the Ten Cate Investment Company
- The company intends to use the funds to facilitate further pre-clinical development and batch production of a regenerative stent for peripheral indications
- The company is a medical device company bringing a novel class of regenerative endovascular implants for the treatment of cardiovascular diseases
- Using a catheter-based approach, these devices provide the ability to restore arteries without the need for an invasive surgical intervention
- The aim is to ultimately restore the affected blood vessel from the inside out to provide a lifelong solution
